Int J Stomatol

Inter J Stomatol ›› 2018, Vol. 45 ›› Issue (4): 480-484.doi: 10.7518/gjkq.2018.04.019

• Reviews • Previous Articles     Next Articles

Gorham-Stout syndrome in the maxillofacial region

Liu Min, Liu Weiwei, Xu Zhimin, Wang Zilin, Li Jiale, Han Bing.   

  1. Dept. of Oral and Maxillofacial Surgery, Hospital of Stomatology, Jilin University;
    Jilin Provincial Key Laboratory of Tooth Development and Bone Remodeling, Changchun 130021, China
  • Received:2017-09-22 Revised:2018-02-17 Online:2018-07-02 Published:2018-07-02
  • Supported by:
    This study was supported by National Natural Science Foundation of China (81602377).

RichHTML

18

PDF (PC)

385

Abstract: Gorham-Stout syndrome, which is also called massive osteolysis, vanishing bone disease, phantom bone disease, is characterized by spontaneous progressie bone resorption, and is a rare disorder in the clinical, whereas the etiology is unknown. Gorham-Stout syndrome is characterized histologically by the proliferation of endothelial-lined vessels in bone and by the replacement of bone with fibrous tissue. Clinical manifestations are diverse. In most cases, only a single bone or several bones are affected. Associated infiltrative soft tissue abnormality is often found. Reports of maxillofacial bone resorption are few. According to the literature of domestic and overseas, the aim of this paper is to make a brief review about the etiology, clinical manifestations, diagnosis and differential diagnosis and therapy of Gorham-Stout syndrome.

Key words: Gorham-Stout syndrome, massive osteolysis, maxillofacial bone

CLC Number: 

  • R782

TrendMD: 
[1] Gorham LW, Stout AP. Massive osteolysis(acute spontaneous absorption of bone, phantom bone, disa-ppearing bone); its relation to hemangiomatosis[J]. J Bone Joint Surg Am,1955, 37-A(5): 985-1004.
[2] Dellinger MT, Garg N, Olsen BR.Viewpoints on vessels and vanishing bones in Gorham-Stout disease[J]. Bone, 2014, 63: 47-52.
[3] Patel DV.Gorham’s disease or massive osteolysis[J]. Clin Med Res, 2005, 3(2): 65-74.
[4] Shi J, Zhang Z, Li Y, et al.Reossification in Gorham’s disease of the hand and wrist with unusual CT and MR imaging features[J]. Skeletal Radiol, 2015, 44(7): 1033-1038.
[5] Yalniz E, Alicioglu B, Benlier E, et al.Gorham-Stout disease of the humerus[J]. JBR-BTR, 2008, 91(1): 14-17.
[6] 游云华, 汪跃平, 梁军, 等. 上颌骨溶骨症一例报告并文献复习[J]. 中华肿瘤防治杂志, 2010, 17(14): 1131-1133.You YH, Wang YP, Liang J, et al.Massive osteo-lysis of maxillary bone: report of one case and litera-ture review[J]. Chin J Cancer Prev Treat, 2010, 17(14): 1131-1133.
[7] 李运良, 刘京兵, 朱兆夫. 颅、颌骨溶解症2例报道[J]. 口腔颌面外科杂志, 2002, 12(2): 183-184.Li YL, Liu JB, Zhu ZF.Report of 2 cases of jaw osteolysis[J]. J Oral Maxillofac Surg, 2002, 12(2): 183-184.
[8] Escande C, Schouman T, Françoise G, et al.Histo-logical features and management of a mandibular Gorham disease: a case report and review of maxil-lofacial cases in the literature[J]. Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 2008, 106(3): e30-e37.
[9] Perschbacher SE, Perschbacher KA, Pharoah MJ, et al.Gorham’s disease of the maxilla: a case report[J]. Dentomaxillofac Radiol, 2010, 39(2): 119-123.
[10] Maillot C, Cloche T, Le Huec JC.Thoracic osteotomy for Gorham-Stout disease of the spine: a case report and literature review[J]. Eur Spine J, 2014. [Epub ahead of print].
[11] Hardegger F, Simpson LA, Segmueller G.The syn-drome of idiopathic osteolysis. Classification, review, and case report[J]. J Bone Joint Surg Br, 1985, 67(1): 88-93.
[12] Busilacchi A, Ramazzotti D, Ulisse S, et al.Gorham-Stout disease as a complication of posterior shoulder capsulorrhaphy[J]. J Shoulder Elbow Surg, 2012, 21(9): e1-e7.
[13] Devlin RD, Bone HG 3rd, Roodman GD. Interleukin-6: a potential mediator of the massive osteolysis in pa-tients with Gorham-Stout disease[J]. J Clin Endo-crinol Metab, 1996, 81(5): 1893-1897.
[14] Hirayama T, Sabokbar A, Itonaga I, et al.Cellular and humoral mechanisms of osteoclast formation and bone resorption in Gorham-Stout disease[J]. J Pathol, 2001, 195(5): 624-630.
[15] Spieth ME, Greenspan A, Forrester DM, et al.Gor-ham’s disease of the radius: radiographic, scintigraphic, and MRI findings with pathologic correlation. A case report and review of the literature[J]. Skeletal Radiol, 1997, 26(11): 659-663.
[16] Venkatramani R, Ma NS, Pitukcheewanont P, et al.Gorham’s disease and diffuse lymphangiomatosis in children and adolescents[J]. Pediatr Blood Cancer, 2011, 56(4): 667-670.
[17] Dupond JL, Bermont L, Runge M, et al.Plasma VEGF determination in disseminated lymphangiomatosis-Gorham-Stout syndrome: a marker of activity? A case report with a 5-year follow-up[J]. Bone, 2010, 46(3): 873-876.
[18] Zhu X, Gao JJ, Landao-Bassonga E, et al.Thonzonium bromide inhibits RANKL-induced osteoclast forma-tion and bone resorption in vitro and prevents LPS-induced bone loss in vivo[J]. Biochem Pharmacol, 2016, 104: 118-130.
[19] Eghbali-Fatourechi G, Khosla S, Sanyal A, et al.Role of RANK ligand in mediating increased bone resorption in early postmenopausal women[J]. J Clin Invest, 2003, 111(8): 1221-1230.
[20] Kong YY, Feige U, Sarosi I, et al.Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand[J]. Nature, 1999, 402(6759): 304-309.
[21] Darnay BG, Ni J, Moore PA, et al.Activation of NF-kappaB by RANK requires tumor necrosis factor receptor-associated factor (TRAF) 6 and NF-kappa B-inducing kinase. Identification of a novel TRAF6 interaction motif[J]. J Biol Chem, 1999, 274(12): 7724-7731.
[22] Armstrong AP, Tometsko ME, Glaccum M, et al.A RANK/TRAF6-dependent signal transduction path-way is essential for osteoclast cytoskeletal organiza-tion and resorptive function[J]. J Biol Chem, 2002, 277(46): 44347-44356.
[23] Feng X.RANKing intracellular signaling in osteo-clasts[J]. IUBMB Life, 2005, 57(6): 389-395.
[24] Kai B, Ryan A, Munk PL, et al.Gorham disease of bone: three cases and review of radiological features[J]. Clin Radiol, 2006, 61(12): 1058-1064.
[25] Zhao SF, Wang YX, Yang XD, et al.Gorham disease of the mandible[J]. J Craniofac Surg, 2015, 26(2): e160-e162.
[26] Yang RH, Chen PC, Chang CP, et al.Gorham’s disease: the disappearing bone[J]. Clin Nucl Med, 2013, 38(5): 361-364.
[27] Lala S, Mulliken JB, Alomari AI, et al.Gorham-Stout disease and generalized lymphatic anomaly—clinical, radiologic, and histologic differentiation[J]. Skeletal Radiol, 2013, 42(7): 917-924.
[28] Alves VM, Vieira TS, Amorim NS, et al.99mTc(V)-DMSA SPECT-CT findings in a case of Gorham-Stout disease[J]. Nucl Med Rev Cent East Eur, 2015, 18(2): 97-101.
[29] Liu Y, Zhong DR, Zhou PR, et al.Gorham-Stout disease: radiological, histological, and clinical fea-tures of 12 cases and review of literature[J]. Clin Rheumatol, 2016, 35(3): 813-823.
[30] Suero Molina EJ, Niederstadt T, Ruland V, et al.Cerebrospinal fluid leakage in Gorham-Stout disease due to dura mater involvement after progression of an osteolytic lesion in the thoracic spine[J]. J Neuro-surg Spine, 2014, 21(6): 956-960.
[31] Choi BS, Hong SJ, Chu MA, et al.Gastrointestinal tract involvement of Gorham’s disease with expre-ssion of D2-40 in duodenum[J]. Pediatr Gastroen-terol Hepatol Nutr, 2014, 17(1): 52-56.
[32] Franchi A, Bertoni F, Bacchini P, et al.CD105/endo-glin expression in Gorham disease of bone[J]. J Clin Pathol, 2009, 62(2): 163-167.
[33] Kuriyama DK, McElligott SC, Glaser DW, et al. Treatment of Gorham-Stout disease with zoledronic acid and interferon-α: a case report and literature review[J]. J Pediatr Hematol Oncol, 2010, 32(8): 579-584.
[34] Edwards JR, Williams K, Kindblom LG, et al.Lym-phatics and bone[J]. Hum Pathol, 2008, 39(1): 49-55.
[35] Chattopadhyay P, Bandyopadhyay A, Das S, et al.Gorham’s disease with spontaneous recovery[J]. Singapore Med J, 2009, 50(7): e259-e263.
[36] Shimizu T, Sato K, Yoshida T, et al.A case report of Gorham-Stout syndrome remission[J]. J Orthop Sci, 2012, 17(2): 199-204.
[37] Lala S, Mulliken JB, Alomari AI, et al.Gorham-Stout disease and generalized lymphatic anomaly—clinical, radiologic, and histologic differentiation[J]. Skeletal Radiol, 2013, 42(7): 917-924.
[38] Ruggieri P, Montalti M, Angelini A, et al.Gorham-Stout disease: the experience of the Rizzoli Institute and review of the literature[J]. Skeletal Radiol, 2011, 40(11): 1391-1397.
[39] Aizawa T, Sato T, Kokubun S.Gorham disease of the spine: a case report and treatment strategies for this enigmatic bone disease[J]. Tohoku J Exp Med, 2005, 205(2): 187-196.
[40] Paley MD, Lloyd CJ, Penfold CN.Total mandibular reconstruction for massive osteolysis of the mandible (Gorham-Stout syndrome)[J]. Br J Oral Maxillofac Surg, 2005, 43(2): 166-168.
[41] Sekharappa V, Arockiaraj J, Amritanand R, et al.Gorham’s disease of spine[J]. Asian Spine J, 2013, 7(3): 242-247.
[42] Lehmann G, Pfeil A, Böttcher J, et al.Benefit of a 17-year long-term bisphosphonate therapy in a pa-tient with Gorham-Stout syndrome[J]. Arch Orthop Trauma Surg, 2009, 129(7): 967-972.
[43] Möller G, Priemel M, Amling M, et al.The Gorham-Stout syndrome (Gorham’s massive osteolysis). A report of six cases with histopathological findings[J]. J Bone Joint Surg Br, 1999, 81(3): 501-506.
[44] Kuriyama DK, McElligott SC, Glaser DW, et al. Treatment of Gorham-Stout disease with zoledronic acid and interferon-α: a case report and literature review[J]. J Pediatr Hematol Oncol, 2010, 32(8): 579-584.
[45] Grunewald TG, Damke L, Maschan M, et al.First report of effective and feasible treatment of multi-focal lymphangiomatosis (Gorham-Stout) with beva-cizumab in a child[J]. Ann Oncol, 2010, 21(8): 1733-1734.
[46] Takahashi A, Ogawa C, Kanazawa T, et al.Remission induced by interferon alfa in a patient with massive osteolysis and extension of lymph-hemangiomatosis: a severe case of Gorham-Stout syndrome[J]. J Pediatr Surg, 2005, 40(3): E47-E50.
[47] Dupond JL, Bermont L, Runge M, et al.Plasma VEGF determination in disseminated lymphangio-matosis-Gorham-Stout syndrome: a marker of activity? A case report with a 5-year follow-up[J]. Bone, 2010, 46(3): 873-876.
[48] 黄慧, 徐作军, 王立, 等. Gorham-Stout综合征五例临床分析并文献复习[J]. 中华内科杂志, 2009, 48(1): 23-27.Huang H, Xu ZJ, Wang L, et al.Clinical features of Gorham-Stout syndrome and literature review[J]. Chin J Int Med, 2009, 48(1): 23-27.
[49] Heyd R, Micke O, Surholt C, et al.Radiation therapy for Gorham-Stout syndrome: results of a national patterns-of-care study and literature review[J]. Int J Radiat Oncol Biol Phys, 2011, 81(3): e179-e185.
[1] Wu Yifan,Lu Hao,Liu Shengwen,Xu Wanlin,Yang Wenjun.. Gorham-Stout disease in maxillofacial bone: a case report and literature review [J]. Int J Stomatol, 2023, 50(4): 445-451.
[2] Zhang Chaoying,Li Yining,Gong Jiaxing,Wang Huiming. Interpretation of the 2022 classification of head and neck tumors by the World Health Organization: odontogenic and maxillofacial bone tumors [J]. Int J Stomatol, 2023, 50(3): 263-271.
[3] Zhang Xidan,Sun Jiyu,Fu Xinliang,Gan Xueqi.. Research progress on the development of mesoporous calcium silicate nanoparticles in endodontics and repairing maxillofacial bone defects [J]. Int J Stomatol, 2022, 49(4): 476-482.
[4] Wang Yang, Shen Yuqin, Yu Wenwen, Sun Xinhua. Reasearch progress on modified mesoporous bioactive glasses for repairing maxillofacial bone defects [J]. Inter J Stomatol, 2018, 45(1): 32-35.
[5] XIE Ke-xian, LIU Deng-gao, WU Yun-tang. Research progress on massive osteolysis [J]. Inter J Stomatol, 2009, 36(6): 712-715.
Viewed
Full text


Abstract

Cited
  Shared   
  Discussed   
[1] . [J]. Foreign Med Sci: Stomatol, 1999, 26(06): .
[2] . [J]. Foreign Med Sci: Stomatol, 1999, 26(06): .
[3] . [J]. Foreign Med Sci: Stomatol, 1999, 26(05): .
[4] . [J]. Foreign Med Sci: Stomatol, 1999, 26(05): .
[5] . [J]. Foreign Med Sci: Stomatol, 1999, 26(05): .
[6] . [J]. Foreign Med Sci: Stomatol, 1999, 26(04): .
[7] . [J]. Foreign Med Sci: Stomatol, 1999, 26(04): .
[8] . [J]. Foreign Med Sci: Stomatol, 1999, 26(04): .
[9] . [J]. Foreign Med Sci: Stomatol, 1999, 26(04): .
[10] . [J]. Foreign Med Sci: Stomatol, 1999, 26(04): .